ENDRA Life Sciences Return on Tangible Equity 2017-2024 | NDRA
Current and historical return on tangible equity values for ENDRA Life Sciences (NDRA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ENDRA Life Sciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.01B | $0.00B | -191.30% |
| 2024-09-30 | $-0.01B | $0.01B | -123.08% |
| 2024-06-30 | $-0.01B | $0.01B | -150.00% |
| 2024-03-31 | $-0.01B | $0.00B | -181.82% |
| 2023-12-31 | $-0.01B | $0.01B | -181.82% |
| 2023-09-30 | $-0.01B | $0.01B | -208.70% |
| 2023-06-30 | $-0.01B | $0.01B | -171.43% |
| 2023-03-31 | $-0.01B | $0.00B | -152.94% |
| 2022-12-31 | $-0.01B | $0.01B | -133.33% |
| 2022-09-30 | $-0.01B | $0.01B | -120.93% |
| 2022-06-30 | $-0.01B | $0.01B | -113.04% |
| 2022-03-31 | $-0.01B | $0.01B | -100.00% |
| 2021-12-31 | $-0.01B | $0.01B | -77.19% |
| 2021-09-30 | $-0.01B | $0.01B | -75.47% |
| 2021-06-30 | $-0.01B | $0.02B | -102.33% |
| 2021-03-31 | $-0.01B | $0.02B | -151.72% |
| 2020-12-31 | $-0.01B | $0.01B | -342.86% |
| 2020-09-30 | $-0.02B | $0.00B | -633.33% |
| 2020-06-30 | $-0.02B | $0.00B | -720.00% |
| 2020-03-31 | $-0.02B | $0.00B | -618.18% |
| 2019-12-31 | $-0.02B | $0.01B | -566.67% |
| 2019-09-30 | $-0.01B | $0.00B | -307.69% |
| 2019-06-30 | $-0.01B | $0.00B | -333.33% |
| 2019-03-31 | $-0.01B | $0.00B | -333.33% |
| 2018-12-31 | $-0.01B | $0.01B | -363.64% |
| 2018-09-30 | $-0.01B | $0.00B | -400.00% |
| 2018-06-30 | $-0.01B | $0.00B | -188.24% |
| 2018-03-31 | $-0.01B | $0.00B | -121.74% |
| 2017-12-31 | $-0.01B | $0.01B | -105.26% |
| 2017-09-30 | $0.00B | $0.01B | -123.08% |
| 2017-06-30 | $0.00B | $0.01B | -266.67% |
| 2017-03-31 | $0.00B | $0.00B | 800.00% |
| 2016-12-31 | $0.00B | $0.00B | 1200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.003B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||